Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial

Although survival has improved for kidney transplant recipients over the past several decades, long-term survival in diabetic cohorts still is significantly less than that of non-diabetic cohorts. We hypothesized that among stable kidney transplant recipients, there might be differences between subg...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinrauch, Larry A, D’Elia, John A, Weir, Matthew R, Bunnapradist, Suphamai, Finn, Peter, Liu, Jiankang, Claggett, Brian, Monaco, Anthony P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571849/
https://www.ncbi.nlm.nih.gov/pubmed/28860838
http://dx.doi.org/10.2147/IJNRD.S139901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571849/
https://www.ncbi.nlm.nih.gov/pubmed/28860838
http://dx.doi.org/10.2147/IJNRD.S139901

Ejemplares similares